Johnson & Johnson Other Non-Current Liabilities 2010-2024 | JNJ

Johnson & Johnson other non-current liabilities for the quarter ending December 31, 2024 were $17.939B, a 10.2% increase year-over-year.

  • Johnson & Johnson other non-current liabilities for 2024 were $17.939B, a 10.2% increase from 2023.
  • Johnson & Johnson other non-current liabilities for 2023 were $16.279B, a 12.64% increase from 2022.
  • Johnson & Johnson other non-current liabilities for 2022 were $14.452B, a 11.87% decline from 2021.

Johnson & Johnson Other Non-Current Liabilities 2010-2024 | JNJ

  • Johnson & Johnson other non-current liabilities for 2024 were $17.939B, a 10.2% increase from 2023.
  • Johnson & Johnson other non-current liabilities for 2023 were $16.279B, a 12.64% increase from 2022.
  • Johnson & Johnson other non-current liabilities for 2022 were $14.452B, a 11.87% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B